Physician profile
Kimberly V Tucker
NPI 1023308988
$17,244.77
in general payments reported to CMS, 2019-2025
21 companies · $6,780 in 2025
The $6,780 reported for 2025 was more than what 84% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $645 · 2021: $152 · 2022: $1,617 · 2023: $2,065 · 2024: $5,870 · 2025: $6,780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,171 · Food and Beverage: $5,544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,171.32 |
| Food and Beverage | $5,543.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seapearl East, INC | $7,430.91 | 2020-2025 | |
| Arthrex, INC. | $3,680.07 | 2022-2025 | |
| Smith+Nephew, INC. | $3,286.11 | 2023-2025 | Healicoil, Q-Fix, Bone Anchors With Arthroscopic Delivery System |
| Stryker Corporation | $1,626.16 | 2021-2025 | Salvation, Iconix, Alphavent |
| Globus Medical, INC. | $219.37 | 2021-2023 | Ankle Fracture System, Troch Nail |
| Zynex Medical, INC. | $173.09 | 2025 | Nexwave |
| Medtronic, INC. | $158.77 | 2024 | Anatomic Peek Ptc Cervical Fusion System |
| Bioventus LLC | $115.66 | 2019-2024 | Durolane |
| Si-Bone, INC. | $109.59 | 2022 | |
| Ferring Pharmaceuticals INC. | $104.17 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $58.79 | 2023 | Nuzyra |
| Depuy Synthes Sales INC. | $57.17 | 2019-2025 | Milagro, Dynatape, Truespan Orthocord |
| Djo, LLC | $47.15 | 2022 | |
| Vericel Corporation | $36.24 | 2022 | |
| Horizon Therapeutics Plc | $27.76 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $26.89 | 2023 | Triluron |
| Spinal Elements, INC. | $20.40 | 2024 | |
| Averitas Pharma INC. | $17.46 | 2024 | Qutenza |
| Heraeus Medical, LLC. | $16.47 | 2021 | |
| Endo USA, INC. | $16.39 | 2025 | Xiaflex |
| Kowa Pharmaceuticals America, INC. | $16.15 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Tucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.